首页> 外文期刊>Protein Expression and Purification >Production of soluble truncated spike protein of porcine epidemic diarrhea virus from inclusion bodies of Escherichia coli through refolding
【24h】

Production of soluble truncated spike protein of porcine epidemic diarrhea virus from inclusion bodies of Escherichia coli through refolding

机译:通过重折叠从大肠杆菌包涵体生产猪流行性腹泻病毒的可溶性截短的刺突蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

The emergence of highly pathogenic variant porcine epidemic diarrhea virus (PEDV) strains, from 2013 to 2014, in North American and Asian countries have greatly threatened global swine industry. Therefore, development of effective vaccines against PEDV variant strains is urgently needed. Recently, it has been reported that the N-terminal domain (NTD) of S1 domain of PEDV spike protein is responsible for binding to the 5-N-acetylneuraminic acid (Neu5Ac), a possible sugar co-receptor. Therefore, the NTD of S1 domain could be an attractive target for the development of subunit vaccines. In this study, the NTD spanning amino acid residues 25-229 (S25-229) of S1 domain of PEDV variant strain was expressed in Escherichia coli BL21 (DE3) in the form of inclusion bodies (IBs). S25-229 IBs were solubilized in 20 mM sodium acetate (pH 4.5) buffer containing 8 M urea and 1 mM dithiothreitol with 95% yield. Solubilized S25-229 IBs were refolded by 10-fold flash dilution and purified by one-step cation exchange chromatography with >95% purity and 20% yield. The CD spectrum of S25-229 showed the characteristic pattern of alpha helical structure. In an indirect ELISA, purified S25-229 showed strong reactivity with mouse anti-PEDV sera. In addition, immunization of mice with 20 mu g of purified S25-229 elicited highly potent serum IgG titers. Finally, mouse antisera against S25-229 showed immune reactivity with native PEDV S protein in an immunofluorescence assay. These results suggest that purified S25-229 may have potential to be used as a subunit vaccine against PEDV variant strains. (C) 2016 Elsevier Inc. All rights reserved.
机译:从2013年至2014年,高致病性猪流行性腹泻病毒(PEDV)菌株的出现在北美和亚洲国家极大地威胁了全球养猪业。因此,迫切需要开发针对PEDV变异株的有效疫苗。最近,据报道,PEDV刺突蛋白的S1结构域的N-末端结构域(NTD)负责与可能的糖共受体5-N-乙酰神经氨酸(Neu5Ac)结合。因此,S1结构域的NTD可能成为亚单位疫苗开发的有吸引力的靶标。在这项研究中,跨越PEDV变异株S1结构域的NTD跨氨基酸残基25-229(S25-229)在大肠杆菌BL21(DE3)中以包涵体(IBs)的形式表达。将S25-229 IBs溶解在含有8 M尿素和1 mM二硫苏糖醇的20 mM乙酸钠(pH 4.5)缓冲液中,产率为95%。通过10倍快速稀释将溶解的S25-229 IBs重新折叠,并通过一步式阳离子交换色谱法纯化,纯度> 95%,收率20%。 S25-229的CD谱显示出α螺旋结构的特征模式。在间接ELISA中,纯化的S25-229与小鼠抗PEDV血清显示强反应性。另外,用20μg纯化的S25-229免疫小鼠会引起高效的血清IgG滴度。最后,在免疫荧光试验中,针对S25-229的小鼠抗血清显示出与天然PEDV S蛋白的免疫反应性。这些结果表明,纯化的S25-229可能具有用作针对PEDV变异株的亚单位疫苗的潜力。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号